af928d9a-10e2-4c06-96b3-84c31be12c40/5-0
00:00:03.299 --> 00:00:06.071
Health South Florida.
He's a Chief Medical Innovation Officer.

af928d9a-10e2-4c06-96b3-84c31be12c40/5-1
00:00:06.071 --> 00:00:08.139
Barry,
thank you so much for joining us today.

af928d9a-10e2-4c06-96b3-84c31be12c40/6-0
00:00:08.219 --> 00:00:09.499
My pleasure, thank you.

af928d9a-10e2-4c06-96b3-84c31be12c40/8-0
00:00:10.059 --> 00:00:13.399
So just for background reference for our
listeners,

af928d9a-10e2-4c06-96b3-84c31be12c40/8-1
00:00:13.399 --> 00:00:18.024
Baptist Health South Florida is
headquartered in Coral Gables, Florida,

af928d9a-10e2-4c06-96b3-84c31be12c40/8-2
00:00:18.024 --> 00:00:21.171
with 2,
300 beds across 12 hospitals serviced by

af928d9a-10e2-4c06-96b3-84c31be12c40/8-3
00:00:21.171 --> 00:00:25.090
6,000 providers. Now,
Barry is the Chief Medical Information

af928d9a-10e2-4c06-96b3-84c31be12c40/8-4
00:00:25.090 --> 00:00:29.329
Officer, acronym is CMIO,
but not the way you traditionally think

af928d9a-10e2-4c06-96b3-84c31be12c40/8-5
00:00:29.329 --> 00:00:31.899
of it. He's not the informatics officer.

af928d9a-10e2-4c06-96b3-84c31be12c40/9-0
00:00:32.259 --> 00:00:36.332
And the reason Baptist Health South
Florida has a Chief Medical Innovation

af928d9a-10e2-4c06-96b3-84c31be12c40/9-1
00:00:36.332 --> 00:00:40.678
Officer is to answer the question of how
do we generate new revenue streams for

af928d9a-10e2-4c06-96b3-84c31be12c40/9-2
00:00:40.678 --> 00:00:44.806
Baptist Health South Florida other than
care delivery or estate real estate

af928d9a-10e2-4c06-96b3-84c31be12c40/9-3
00:00:44.806 --> 00:00:47.196
management as margins are being
compressed.

af928d9a-10e2-4c06-96b3-84c31be12c40/9-4
00:00:47.196 --> 00:00:49.640
Every organization across the United
States,

af928d9a-10e2-4c06-96b3-84c31be12c40/9-5
00:00:49.640 --> 00:00:52.139
every provider organization is facing
similar

af928d9a-10e2-4c06-96b3-84c31be12c40/10-0
00:00:52.219 --> 00:00:57.185
pressures facing their margins.
So today we're going to be discussing a

af928d9a-10e2-4c06-96b3-84c31be12c40/10-1
00:00:57.185 --> 00:01:02.565
variety of ways in which Barry has led
BHSF's efforts to generate new revenue

af928d9a-10e2-4c06-96b3-84c31be12c40/10-2
00:01:02.565 --> 00:01:06.772
streams from developing AI applications,
commercializing IP,

af928d9a-10e2-4c06-96b3-84c31be12c40/10-3
00:01:06.772 --> 00:01:12.359
and Barry's going to talk about a few
other kind of processes as well. So Barry,

af928d9a-10e2-4c06-96b3-84c31be12c40/10-4
00:01:12.359 --> 00:01:13.739
welcome to the show.

af928d9a-10e2-4c06-96b3-84c31be12c40/11-0
00:01:14.059 --> 00:01:17.584
And please tell us a little bit about the
genesis of your role and then let's go

af928d9a-10e2-4c06-96b3-84c31be12c40/11-1
00:01:17.584 --> 00:01:20.195
into how you're doing it,
what you're doing with your role.

af928d9a-10e2-4c06-96b3-84c31be12c40/11-2
00:01:20.195 --> 00:01:22.459
I think a lot of listeners would like to
hear that.

af928d9a-10e2-4c06-96b3-84c31be12c40/12-0
00:01:22.939 --> 00:01:26.655
Yeah, thanks so much. Yeah,
it's a pleasure to be here and share this

af928d9a-10e2-4c06-96b3-84c31be12c40/12-1
00:01:26.655 --> 00:01:29.734
with you. Well,
for many years I was in clinical practice

af928d9a-10e2-4c06-96b3-84c31be12c40/12-2
00:01:29.734 --> 00:01:32.335
primarily.
I founded and developed the Heart and

af928d9a-10e2-4c06-96b3-84c31be12c40/12-3
00:01:32.335 --> 00:01:34.724
Vascular Institute within our health
system,

af928d9a-10e2-4c06-96b3-84c31be12c40/12-4
00:01:34.724 --> 00:01:38.493
which grew into a system-wide
organization and basically lived my life

af928d9a-10e2-4c06-96b3-84c31be12c40/12-5
00:01:38.493 --> 00:01:42.899
in a world of innovation for most of my
career. Kind of winding down the back end,

af928d9a-10e2-4c06-96b3-84c31be12c40/14-0
00:01:43.179 --> 00:01:47.932
It seemed to me that our health system
had grown to the point where there was a

af928d9a-10e2-4c06-96b3-84c31be12c40/14-1
00:01:47.932 --> 00:01:52.151
huge amount of intellectual property
residing within our organization,

af928d9a-10e2-4c06-96b3-84c31be12c40/14-2
00:01:52.151 --> 00:01:55.657
which represented an asset and a
potential opportunity for

af928d9a-10e2-4c06-96b3-84c31be12c40/14-3
00:01:55.657 --> 00:01:58.688
commercialization if we could put things
together.

af928d9a-10e2-4c06-96b3-84c31be12c40/14-4
00:01:58.688 --> 00:02:01.659
And so I worked with the board about a
decade ago

af928d9a-10e2-4c06-96b3-84c31be12c40/16-0
00:02:01.979 --> 00:02:06.697
to change our vision statement and
introduce the commitment to innovation

af928d9a-10e2-4c06-96b3-84c31be12c40/16-1
00:02:06.697 --> 00:02:11.097
into our vision statement and began to
create an innovation program.

af928d9a-10e2-4c06-96b3-84c31be12c40/16-2
00:02:11.097 --> 00:02:15.688
I'll sort of skip through the details
about version 1.0 to 2.0 and 3.0,

af928d9a-10e2-4c06-96b3-84c31be12c40/15-0
00:02:13.179 --> 00:02:13.499
Good.

af928d9a-10e2-4c06-96b3-84c31be12c40/16-3
00:02:15.688 --> 00:02:18.876
but it's been an evolutionary process in
general.

af928d9a-10e2-4c06-96b3-84c31be12c40/16-4
00:02:18.876 --> 00:02:23.659
I do want to say that I worked together
with a collaborative partner who's

af928d9a-10e2-4c06-96b3-84c31be12c40/18-0
00:02:24.059 --> 00:02:27.745
comes from the business world and
innovation, Mark Kotikia,

af928d9a-10e2-4c06-96b3-84c31be12c40/18-1
00:02:27.745 --> 00:02:31.615
and he's my corporate dyad,
corporate vice president who works

af928d9a-10e2-4c06-96b3-84c31be12c40/17-0
00:02:31.139 --> 00:02:31.739
Mm-hmm.

af928d9a-10e2-4c06-96b3-84c31be12c40/18-2
00:02:31.615 --> 00:02:35.055
together with me.
And so we began to look around, well,

af928d9a-10e2-4c06-96b3-84c31be12c40/18-3
00:02:35.055 --> 00:02:39.048
what assets do we have?
We have the intellectual property of the

af928d9a-10e2-4c06-96b3-84c31be12c40/18-4
00:02:39.048 --> 00:02:43.779
physicians and the increasing quality of
physicians' knowledge and know-how.

af928d9a-10e2-4c06-96b3-84c31be12c40/19-0
00:02:44.139 --> 00:02:47.784
We have data which seems to be of
increasing value,

af928d9a-10e2-4c06-96b3-84c31be12c40/19-1
00:02:47.784 --> 00:02:52.620
particularly in the world of development
of artificial intelligence,

af928d9a-10e2-4c06-96b3-84c31be12c40/19-2
00:02:52.620 --> 00:02:57.457
where data is so important.
And then we have a huge amount of assets

af928d9a-10e2-4c06-96b3-84c31be12c40/19-3
00:02:57.457 --> 00:03:01.522
in the people that represent those within
Baptist Health.

af928d9a-10e2-4c06-96b3-84c31be12c40/19-4
00:03:01.522 --> 00:03:06.219
So we have several different options of
ways we can approach this.

af928d9a-10e2-4c06-96b3-84c31be12c40/21-0
00:03:07.259 --> 00:03:10.284
One of the ways is just promoting
ideation.

af928d9a-10e2-4c06-96b3-84c31be12c40/21-1
00:03:10.284 --> 00:03:15.854
One of the examples we have is our chief
of a supply chain had an idea about how

af928d9a-10e2-4c06-96b3-84c31be12c40/20-0
00:03:12.379 --> 00:03:13.019
Mm-hmm.

af928d9a-10e2-4c06-96b3-84c31be12c40/21-2
00:03:15.854 --> 00:03:21.286
to make things more cost effective and
more efficient within the supply chain.

af928d9a-10e2-4c06-96b3-84c31be12c40/21-3
00:03:21.286 --> 00:03:26.168
Through the innovation program,
we provided the infrastructure and the

af928d9a-10e2-4c06-96b3-84c31be12c40/21-4
00:03:26.168 --> 00:03:27.819
abilities to patent that

af928d9a-10e2-4c06-96b3-84c31be12c40/22-0
00:03:28.179 --> 00:03:31.064
develop it and ultimately commercialize
it.

af928d9a-10e2-4c06-96b3-84c31be12c40/22-1
00:03:31.064 --> 00:03:36.114
And ultimately it came to a successful
licensing arrangement with one of the

af928d9a-10e2-4c06-96b3-84c31be12c40/22-2
00:03:36.114 --> 00:03:40.179
Salesforce companies.
And now it's been successfully licensed

af928d9a-10e2-4c06-96b3-84c31be12c40/22-3
00:03:40.179 --> 00:03:44.573
so far into two major healthcare systems
around the United States.

af928d9a-10e2-4c06-96b3-84c31be12c40/22-4
00:03:44.573 --> 00:03:47.459
And it's generating a modest annual
income.

af928d9a-10e2-4c06-96b3-84c31be12c40/23-0
00:03:47.739 --> 00:03:52.479
that's applying both the organization and
also rewarding the creator or the

af928d9a-10e2-4c06-96b3-84c31be12c40/23-1
00:03:52.479 --> 00:03:56.284
inventor, the co-creator,
because of a generous intellectual

af928d9a-10e2-4c06-96b3-84c31be12c40/23-2
00:03:56.284 --> 00:03:58.779
property policy that we have internally.

af928d9a-10e2-4c06-96b3-84c31be12c40/25-0
00:03:59.179 --> 00:04:04.481
Interesting. I'd like to dial in on that.
We can proceed to the other use cases in

af928d9a-10e2-4c06-96b3-84c31be12c40/24-0
00:04:00.779 --> 00:04:01.259
Dial.

af928d9a-10e2-4c06-96b3-84c31be12c40/25-1
00:04:04.481 --> 00:04:07.739
a moment,
but I think it'd be of greatest interest

af928d9a-10e2-4c06-96b3-84c31be12c40/25-2
00:04:07.739 --> 00:04:11.252
to our listeners to hear about this
specific use case.

af928d9a-10e2-4c06-96b3-84c31be12c40/25-3
00:04:11.252 --> 00:04:16.619
So there's a few ways we can tackle this.
One is you encourage innovation and ideas

af928d9a-10e2-4c06-96b3-84c31be12c40/25-4
00:04:16.619 --> 00:04:20.324
at the organization.
You provide an intellectual property

af928d9a-10e2-4c06-96b3-84c31be12c40/25-5
00:04:20.324 --> 00:04:20.899
framework

af928d9a-10e2-4c06-96b3-84c31be12c40/26-0
00:04:20.979 --> 00:04:24.094
that would generate revenue streams for
the organization,

af928d9a-10e2-4c06-96b3-84c31be12c40/26-1
00:04:24.094 --> 00:04:27.799
but also reward the person who came up
with the idea. And of course,

af928d9a-10e2-4c06-96b3-84c31be12c40/26-2
00:04:27.799 --> 00:04:32.257
there's a variety of technical challenges
to make sure that there's the right data

af928d9a-10e2-4c06-96b3-84c31be12c40/26-3
00:04:32.257 --> 00:04:36.768
available at the right time and place in
order to enable this solution to function.

af928d9a-10e2-4c06-96b3-84c31be12c40/26-4
00:04:36.768 --> 00:04:40.796
So would you please just start with
describing what the solution is within

af928d9a-10e2-4c06-96b3-84c31be12c40/26-5
00:04:40.796 --> 00:04:42.139
the supply chain vertical

af928d9a-10e2-4c06-96b3-84c31be12c40/27-0
00:04:42.699 --> 00:04:47.225
just a brief high-level overview,
and then go into what some of the

af928d9a-10e2-4c06-96b3-84c31be12c40/27-1
00:04:47.225 --> 00:04:51.019
challenges are with developing that
particular solution.

af928d9a-10e2-4c06-96b3-84c31be12c40/30-0
00:04:51.339 --> 00:04:54.331
So I'm not an expert in supply chain
management,

af928d9a-10e2-4c06-96b3-84c31be12c40/28-0
00:04:54.219 --> 00:04:54.419
No.

af928d9a-10e2-4c06-96b3-84c31be12c40/30-1
00:04:54.331 --> 00:04:57.506
and I may not be able to articulate this
correctly,

af928d9a-10e2-4c06-96b3-84c31be12c40/30-2
00:04:57.506 --> 00:05:01.964
but my understanding is that people in
supply chain are constantly being

af928d9a-10e2-4c06-96b3-84c31be12c40/29-0
00:05:01.179 --> 00:05:01.659
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/30-3
00:05:01.964 --> 00:05:06.972
confronted with either price changes or
changing orders and things like that that

af928d9a-10e2-4c06-96b3-84c31be12c40/30-4
00:05:06.972 --> 00:05:09.659
basically lead to errors and other types
of

af928d9a-10e2-4c06-96b3-84c31be12c40/32-0
00:05:10.219 --> 00:05:13.361
delays in terms of management of supply
chain.

af928d9a-10e2-4c06-96b3-84c31be12c40/31-0
00:05:13.099 --> 00:05:13.699
Mm-hmm.

af928d9a-10e2-4c06-96b3-84c31be12c40/32-1
00:05:13.361 --> 00:05:18.842
And this software that was developed by
our chief supply chain officer is able to

af928d9a-10e2-4c06-96b3-84c31be12c40/32-2
00:05:18.842 --> 00:05:23.989
manage that basically on the front end
and in the background and was able to

af928d9a-10e2-4c06-96b3-84c31be12c40/32-3
00:05:23.989 --> 00:05:28.334
produce measurable reduction in these by
about 20 to 30 percent,

af928d9a-10e2-4c06-96b3-84c31be12c40/32-4
00:05:28.334 --> 00:05:29.939
which resulted in direct

af928d9a-10e2-4c06-96b3-84c31be12c40/34-0
00:05:30.219 --> 00:05:34.643
and indirect cost savings that was at
first measurable to Pap to South,

af928d9a-10e2-4c06-96b3-84c31be12c40/34-1
00:05:34.643 --> 00:05:39.681
where we piloted it. And then ultimately,
it's been proven to bring cost efficacy

af928d9a-10e2-4c06-96b3-84c31be12c40/34-2
00:05:39.681 --> 00:05:44.536
to other organizations that are licensing
it. So the process was by, you know,

af928d9a-10e2-4c06-96b3-84c31be12c40/34-3
00:05:44.536 --> 00:05:48.652
how we did this was somebody had an idea.
We encouraged that idea.

af928d9a-10e2-4c06-96b3-84c31be12c40/33-0
00:05:46.939 --> 00:05:47.179
Hmm.

af928d9a-10e2-4c06-96b3-84c31be12c40/34-4
00:05:48.652 --> 00:05:50.619
We have an intellectual property

af928d9a-10e2-4c06-96b3-84c31be12c40/36-0
00:05:50.859 --> 00:05:53.808
policy.
We don't have a huge amount of resources

af928d9a-10e2-4c06-96b3-84c31be12c40/36-1
00:05:53.808 --> 00:05:57.119
internally to develop algorithms and
things like that.

af928d9a-10e2-4c06-96b3-84c31be12c40/35-0
00:05:54.819 --> 00:05:55.299
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/36-2
00:05:57.119 --> 00:05:59.949
So the innovation program,
our program itself,

af928d9a-10e2-4c06-96b3-84c31be12c40/36-3
00:05:59.949 --> 00:06:04.945
has a model of using outside experts and
outside resources rather than building an

af928d9a-10e2-4c06-96b3-84c31be12c40/36-4
00:06:04.945 --> 00:06:09.099
entire infrastructure or maker space that
might be required for both

af928d9a-10e2-4c06-96b3-84c31be12c40/37-0
00:06:10.859 --> 00:06:14.291
data creation as well as medical device
creation.

af928d9a-10e2-4c06-96b3-84c31be12c40/37-1
00:06:14.291 --> 00:06:19.852
So our model and innovation is actually
to outsource those and work with outside

af928d9a-10e2-4c06-96b3-84c31be12c40/37-2
00:06:19.852 --> 00:06:20.539
resources.

af928d9a-10e2-4c06-96b3-84c31be12c40/38-0
00:06:20.859 --> 00:06:23.656
And by the way,
if our listeners are interested in

af928d9a-10e2-4c06-96b3-84c31be12c40/38-1
00:06:23.656 --> 00:06:27.385
learning more about how to access this
particular software product,

af928d9a-10e2-4c06-96b3-84c31be12c40/38-2
00:06:27.385 --> 00:06:31.444
I imagine you're licensing it to other
provider organizations in America,

af928d9a-10e2-4c06-96b3-84c31be12c40/38-3
00:06:31.444 --> 00:06:33.419
and if so, how would they access it?

af928d9a-10e2-4c06-96b3-84c31be12c40/41-0
00:06:33.419 --> 00:06:37.435
Yeah, right now, right now,
I think it's being marketed through

af928d9a-10e2-4c06-96b3-84c31be12c40/41-1
00:06:37.435 --> 00:06:40.448
Penrod, a company called Penrod.
But otherwise,

af928d9a-10e2-4c06-96b3-84c31be12c40/41-2
00:06:40.448 --> 00:06:43.272
I would say if people want more
information,

af928d9a-10e2-4c06-96b3-84c31be12c40/39-0
00:06:41.339 --> 00:06:41.819
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/41-3
00:06:43.272 --> 00:06:47.979
they can send me an e-mail and I'll make
sure they get to the right place.

af928d9a-10e2-4c06-96b3-84c31be12c40/40-0
00:06:46.459 --> 00:06:46.619
Mm.

af928d9a-10e2-4c06-96b3-84c31be12c40/42-0
00:06:48.299 --> 00:06:51.555
Sounds good.
So let's move on from supply chain.

af928d9a-10e2-4c06-96b3-84c31be12c40/42-1
00:06:51.555 --> 00:06:56.939
Let's talk about what other IP you've
been generating, specifically around data.

af928d9a-10e2-4c06-96b3-84c31be12c40/42-2
00:06:56.939 --> 00:07:01.591
I know that data is especially important
with the Gen. AI revolution.

af928d9a-10e2-4c06-96b3-84c31be12c40/42-3
00:07:01.591 --> 00:07:05.579
So what are you doing around data to
commercialize your IP?

af928d9a-10e2-4c06-96b3-84c31be12c40/44-0
00:07:06.539 --> 00:07:09.642
Well, obviously,
the amount of incomings with artificial

af928d9a-10e2-4c06-96b3-84c31be12c40/44-1
00:07:09.642 --> 00:07:13.833
intelligence companies that are coming
into health systems and wanting to be

af928d9a-10e2-4c06-96b3-84c31be12c40/43-0
00:07:13.579 --> 00:07:14.139
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/44-2
00:07:13.833 --> 00:07:18.352
selling or be engaged here is increasing.
So one of the things innovations does is

af928d9a-10e2-4c06-96b3-84c31be12c40/44-3
00:07:18.352 --> 00:07:22.598
we try and ferret out those which are
commercial arrangements and those which

af928d9a-10e2-4c06-96b3-84c31be12c40/44-4
00:07:22.598 --> 00:07:24.939
may have co-creation opportunities.
That's

af928d9a-10e2-4c06-96b3-84c31be12c40/45-0
00:07:25.179 --> 00:07:30.191
our principal interest in innovation.
So one of the projects we're working on

af928d9a-10e2-4c06-96b3-84c31be12c40/45-1
00:07:30.191 --> 00:07:33.918
right now is actually in the orthopedic
space. Obviously,

af928d9a-10e2-4c06-96b3-84c31be12c40/45-2
00:07:33.918 --> 00:07:39.124
orthopedics is a very highly focused area
and target for cost reduction and also

af928d9a-10e2-4c06-96b3-84c31be12c40/45-3
00:07:39.124 --> 00:07:43.172
quality improvement.
And we're working with an Israeli startup

af928d9a-10e2-4c06-96b3-84c31be12c40/45-4
00:07:43.172 --> 00:07:44.779
company called Project M.

af928d9a-10e2-4c06-96b3-84c31be12c40/47-0
00:07:45.539 --> 00:07:50.868
Two of our subject matter experts are
leaders in orthopedics in our orthopedics

af928d9a-10e2-4c06-96b3-84c31be12c40/47-1
00:07:50.868 --> 00:07:54.265
institute.
And they're working together to use our

af928d9a-10e2-4c06-96b3-84c31be12c40/47-2
00:07:54.265 --> 00:07:59.395
data to create a real-time AI tool that
will allow physicians to have better

af928d9a-10e2-4c06-96b3-84c31be12c40/47-3
00:07:59.395 --> 00:08:03.259
decision-making in the course of treating
their patients.

af928d9a-10e2-4c06-96b3-84c31be12c40/46-0
00:08:03.659 --> 00:08:04.139
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/48-0
00:08:04.339 --> 00:08:07.566
is based on their own track records,
our own results,

af928d9a-10e2-4c06-96b3-84c31be12c40/48-1
00:08:07.566 --> 00:08:11.153
as well as taking data from other
potential health systems.

af928d9a-10e2-4c06-96b3-84c31be12c40/48-2
00:08:11.153 --> 00:08:15.396
So that co-creation project that's going
on right now will ultimately,

af928d9a-10e2-4c06-96b3-84c31be12c40/48-3
00:08:15.396 --> 00:08:19.999
if it generates revenue and is successful,
will generate revenue back to the

af928d9a-10e2-4c06-96b3-84c31be12c40/48-4
00:08:19.999 --> 00:08:24.781
organization and back to the co-creators,
which in this case are two orthopedic

af928d9a-10e2-4c06-96b3-84c31be12c40/48-5
00:08:24.781 --> 00:08:25.259
leaders.

af928d9a-10e2-4c06-96b3-84c31be12c40/49-0
00:08:25.899 --> 00:08:29.234
So, Barry,
I just want to focus in on the concept of

af928d9a-10e2-4c06-96b3-84c31be12c40/49-1
00:08:29.234 --> 00:08:32.695
co-creation. Now,
you mentioned that you don't have an

af928d9a-10e2-4c06-96b3-84c31be12c40/49-2
00:08:32.695 --> 00:08:37.604
internal software development shop and
you often rely on external experts and

af928d9a-10e2-4c06-96b3-84c31be12c40/49-3
00:08:37.604 --> 00:08:40.436
resources.
You have no internal maker space,

af928d9a-10e2-4c06-96b3-84c31be12c40/49-4
00:08:40.436 --> 00:08:44.779
I believe is what you said.
So is co-creation that you actually have

af928d9a-10e2-4c06-96b3-84c31be12c40/50-0
00:08:45.339 --> 00:08:50.558
employees of Baptist Health South Florida
who are co-creating this Project M

af928d9a-10e2-4c06-96b3-84c31be12c40/50-1
00:08:50.558 --> 00:08:54.355
software product?
Or is the co-creation you're allowing

af928d9a-10e2-4c06-96b3-84c31be12c40/50-2
00:08:54.355 --> 00:08:59.642
Project M to leverage your PHI and other
clinical data or any kind of data at

af928d9a-10e2-4c06-96b3-84c31be12c40/50-3
00:08:59.642 --> 00:09:04.659
Baptist Health South Florida and that's
your contribution to the product?

af928d9a-10e2-4c06-96b3-84c31be12c40/55-0
00:09:05.259 --> 00:09:09.351
Okay, so in all fairness,
we do have tremendous internal resources.

af928d9a-10e2-4c06-96b3-84c31be12c40/55-1
00:09:09.351 --> 00:09:12.060
Most of them are very busy dealing with
EHR,

af928d9a-10e2-4c06-96b3-84c31be12c40/55-2
00:09:12.060 --> 00:09:16.453
generation of new internally driven AI
that may or may not have any real

af928d9a-10e2-4c06-96b3-84c31be12c40/51-0
00:09:12.539 --> 00:09:13.019
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/52-0
00:09:15.299 --> 00:09:15.779
Mmh.

af928d9a-10e2-4c06-96b3-84c31be12c40/55-3
00:09:16.453 --> 00:09:19.944
commercializable value,
but they're busy dealing with the

af928d9a-10e2-4c06-96b3-84c31be12c40/53-0
00:09:18.379 --> 00:09:18.659
Yeah.

af928d9a-10e2-4c06-96b3-84c31be12c40/55-4
00:09:19.944 --> 00:09:23.013
clinical enterprise.
What we're doing with outside

af928d9a-10e2-4c06-96b3-84c31be12c40/55-5
00:09:23.013 --> 00:09:24.699
organizations like Project M

af928d9a-10e2-4c06-96b3-84c31be12c40/57-0
00:09:24.979 --> 00:09:28.292
is they're providing the technology.
And we, Baptist Health,

af928d9a-10e2-4c06-96b3-84c31be12c40/54-0
00:09:25.019 --> 00:09:25.499
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/57-1
00:09:28.292 --> 00:09:32.583
are providing the know-how, the patients,
and the data. The clinical know-how,

af928d9a-10e2-4c06-96b3-84c31be12c40/56-0
00:09:32.059 --> 00:09:32.539
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/57-2
00:09:32.583 --> 00:09:36.548
the clinical expertise, and the data.
And that's where it's coming from.

af928d9a-10e2-4c06-96b3-84c31be12c40/57-3
00:09:36.548 --> 00:09:39.970
So in this particular case,
they're actually doing the product

af928d9a-10e2-4c06-96b3-84c31be12c40/57-4
00:09:39.970 --> 00:09:44.207
development with our data that's being
licensed after being de-identified and

af928d9a-10e2-4c06-96b3-84c31be12c40/57-5
00:09:44.207 --> 00:09:44.859
quarantined.

af928d9a-10e2-4c06-96b3-84c31be12c40/58-0
00:09:45.499 --> 00:09:51.419
Got it. So the data is de-identified.
And then I think some of our listeners

af928d9a-10e2-4c06-96b3-84c31be12c40/58-1
00:09:51.419 --> 00:09:55.647
will be interested in a commercialization
application.

af928d9a-10e2-4c06-96b3-84c31be12c40/58-2
00:09:55.647 --> 00:10:01.567
So Project M brings you a real-time
decision-making tool to support surgeons

af928d9a-10e2-4c06-96b3-84c31be12c40/58-3
00:10:01.567 --> 00:10:03.259
in the operating room.

af928d9a-10e2-4c06-96b3-84c31be12c40/59-0
00:10:03.739 --> 00:10:07.137
and you provide your know-how,
your expertise,

af928d9a-10e2-4c06-96b3-84c31be12c40/59-1
00:10:07.137 --> 00:10:11.908
and your de-identified data,
and then you start licensing that to

af928d9a-10e2-4c06-96b3-84c31be12c40/59-2
00:10:11.908 --> 00:10:17.836
other provider organizations around the
country, where is the revenue gain there?

af928d9a-10e2-4c06-96b3-84c31be12c40/59-3
00:10:17.836 --> 00:10:21.524
Is there,
what's the commercialization opportunity

af928d9a-10e2-4c06-96b3-84c31be12c40/59-4
00:10:21.524 --> 00:10:23.259
in this particular case?

af928d9a-10e2-4c06-96b3-84c31be12c40/62-0
00:10:23.299 --> 00:10:27.406
So according to our intellectual property
policy internally,

af928d9a-10e2-4c06-96b3-84c31be12c40/62-1
00:10:27.406 --> 00:10:32.927
whatever the licensing opportunity is or
whatever the transactional aspects of it

af928d9a-10e2-4c06-96b3-84c31be12c40/62-2
00:10:32.927 --> 00:10:38.247
are, will generate a certain revenue,
hopefully successful. We ensure success,

af928d9a-10e2-4c06-96b3-84c31be12c40/60-0
00:10:37.259 --> 00:10:38.299
Mhm, mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/62-3
00:10:38.247 --> 00:10:41.344
obviously,
by making sure there's unmet need,

af928d9a-10e2-4c06-96b3-84c31be12c40/62-4
00:10:41.344 --> 00:10:43.499
making sure our clinical experts

af928d9a-10e2-4c06-96b3-84c31be12c40/66-0
00:10:43.819 --> 00:10:47.334
think this is the value and would
actually help them.

af928d9a-10e2-4c06-96b3-84c31be12c40/61-0
00:10:44.019 --> 00:10:44.499
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/66-1
00:10:47.334 --> 00:10:52.216
That's the real killer app from a
clinical point of view and what we bring

af928d9a-10e2-4c06-96b3-84c31be12c40/64-0
00:10:51.019 --> 00:10:51.499
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/66-2
00:10:52.216 --> 00:10:55.406
to the table.
So let's say whatever revenue gets

af928d9a-10e2-4c06-96b3-84c31be12c40/66-3
00:10:55.406 --> 00:10:59.572
generated within our own organization
back to the organization,

af928d9a-10e2-4c06-96b3-84c31be12c40/65-0
00:10:57.979 --> 00:10:58.459
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/66-4
00:10:59.572 --> 00:11:03.739
50% goes to the creators and 50% goes
back to the organization.

af928d9a-10e2-4c06-96b3-84c31be12c40/68-0
00:11:04.539 --> 00:11:10.512
after payment of expenses that may have
been occurred. So it's after net,

af928d9a-10e2-4c06-96b3-84c31be12c40/68-1
00:11:10.512 --> 00:11:16.888
basically net revenue, after expense.
That 50% goes to the creators of the 50%

af928d9a-10e2-4c06-96b3-84c31be12c40/67-0
00:11:12.619 --> 00:11:13.179
Got it.

af928d9a-10e2-4c06-96b3-84c31be12c40/68-2
00:11:16.888 --> 00:11:22.619
that goes to the organization.
50% will go back to the corporate area.

af928d9a-10e2-4c06-96b3-84c31be12c40/70-0
00:11:23.019 --> 00:11:27.385
A certain amount goes back to the
institute where the physicians may come

af928d9a-10e2-4c06-96b3-84c31be12c40/69-0
00:11:25.339 --> 00:11:25.899
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/70-1
00:11:27.385 --> 00:11:30.041
from,
and a small percentage goes to support

af928d9a-10e2-4c06-96b3-84c31be12c40/70-2
00:11:30.041 --> 00:11:31.339
innovation operations.

af928d9a-10e2-4c06-96b3-84c31be12c40/72-0
00:11:31.499 --> 00:11:35.843
So is Project M rolled out
enterprise-wide across Baptist Health

af928d9a-10e2-4c06-96b3-84c31be12c40/72-1
00:11:35.843 --> 00:11:36.779
South Florida?

af928d9a-10e2-4c06-96b3-84c31be12c40/76-0
00:11:37.419 --> 00:11:42.238
Currently, it's in a pilot phase.
So the way this generally operates,

af928d9a-10e2-4c06-96b3-84c31be12c40/73-0
00:11:39.579 --> 00:11:40.139
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/76-1
00:11:42.238 --> 00:11:45.405
Baptist Health is a very large health
system.

af928d9a-10e2-4c06-96b3-84c31be12c40/74-0
00:11:45.179 --> 00:11:45.699
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/76-2
00:11:45.405 --> 00:11:50.155
Innovation generally works in pockets.
So we identify areas that are

af928d9a-10e2-4c06-96b3-84c31be12c40/75-0
00:11:49.099 --> 00:11:49.579
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/76-3
00:11:50.155 --> 00:11:55.525
particularly good for innovation and
development of new ideas and disruption,

af928d9a-10e2-4c06-96b3-84c31be12c40/76-4
00:11:55.525 --> 00:11:57.659
and then do a successful pilot.

af928d9a-10e2-4c06-96b3-84c31be12c40/78-0
00:11:57.899 --> 00:12:02.102
Once we develop a pilot,
then it's up to the health system to roll

af928d9a-10e2-4c06-96b3-84c31be12c40/78-1
00:12:02.102 --> 00:12:05.803
it out system-wide.
So innovations for us is opportunistic

af928d9a-10e2-4c06-96b3-84c31be12c40/78-2
00:12:05.803 --> 00:12:10.194
rather than strategic. Hopefully,
we'll create a product that will be

af928d9a-10e2-4c06-96b3-84c31be12c40/77-0
00:12:06.899 --> 00:12:07.379
Mmh.

af928d9a-10e2-4c06-96b3-84c31be12c40/78-3
00:12:10.194 --> 00:12:12.954
useful for the entire system,
but it's not,

af928d9a-10e2-4c06-96b3-84c31be12c40/78-4
00:12:12.954 --> 00:12:14.899
we'll commercialize it outside.

af928d9a-10e2-4c06-96b3-84c31be12c40/80-0
00:12:15.419 --> 00:12:18.762
Got it.
And then are you hosting this Project M

af928d9a-10e2-4c06-96b3-84c31be12c40/80-1
00:12:18.762 --> 00:12:22.873
software on-prem,
or is there a cloud deployment strategy,

af928d9a-10e2-4c06-96b3-84c31be12c40/80-2
00:12:22.873 --> 00:12:27.819
especially this might be useful for
selling it to other organizations?

af928d9a-10e2-4c06-96b3-84c31be12c40/79-0
00:12:23.419 --> 00:12:23.739
Wow.

af928d9a-10e2-4c06-96b3-84c31be12c40/81-0
00:12:27.899 --> 00:12:29.979
Right, so it's all gonna be cloud-based.

af928d9a-10e2-4c06-96b3-84c31be12c40/82-0
00:12:31.099 --> 00:12:34.539
Okay,
so it's software as a service essentially.

af928d9a-10e2-4c06-96b3-84c31be12c40/83-0
00:12:34.139 --> 00:12:34.859
Yeah, yeah.

af928d9a-10e2-4c06-96b3-84c31be12c40/84-0
00:12:36.299 --> 00:12:38.699
Perfect.
And then you mentioned that it's

af928d9a-10e2-4c06-96b3-84c31be12c40/84-1
00:12:38.699 --> 00:12:41.899
de-identified.
Can you talk about the process of taking

af928d9a-10e2-4c06-96b3-84c31be12c40/84-2
00:12:41.899 --> 00:12:46.184
the PHI at Baptist Health South Florida
and making it consumable for these

af928d9a-10e2-4c06-96b3-84c31be12c40/84-3
00:12:46.184 --> 00:12:46.699
startups?

af928d9a-10e2-4c06-96b3-84c31be12c40/86-0
00:12:48.299 --> 00:12:51.779
I think that's the biggest barrier to
success,

af928d9a-10e2-4c06-96b3-84c31be12c40/85-0
00:12:51.139 --> 00:12:51.619
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/86-1
00:12:51.779 --> 00:12:57.703
and there's not a short answer to it.
We've been dealing with this for the last

af928d9a-10e2-4c06-96b3-84c31be12c40/86-2
00:12:57.703 --> 00:13:01.850
two or three years.
Actually getting the identification

af928d9a-10e2-4c06-96b3-84c31be12c40/86-3
00:13:01.850 --> 00:13:06.219
process in place that meets the safety
requirements of our

af928d9a-10e2-4c06-96b3-84c31be12c40/89-0
00:13:06.539 --> 00:13:09.896
T&D people,
our technology and digital people,

af928d9a-10e2-4c06-96b3-84c31be12c40/89-1
00:13:09.896 --> 00:13:14.439
has really been a challenge.
It's been really one of the barriers to

af928d9a-10e2-4c06-96b3-84c31be12c40/87-0
00:13:11.299 --> 00:13:11.779
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/89-2
00:13:14.439 --> 00:13:17.402
actually moving this entire process
forward.

af928d9a-10e2-4c06-96b3-84c31be12c40/89-3
00:13:17.402 --> 00:13:22.603
We're making huge progress right now.
Baptist Health is also in the process of

af928d9a-10e2-4c06-96b3-84c31be12c40/89-4
00:13:22.603 --> 00:13:25.960
changing our EMR,
which obviously sucks tremendous

af928d9a-10e2-4c06-96b3-84c31be12c40/89-5
00:13:25.960 --> 00:13:26.619
bandwidth.

af928d9a-10e2-4c06-96b3-84c31be12c40/88-0
00:13:26.939 --> 00:13:27.419
Yeah.

af928d9a-10e2-4c06-96b3-84c31be12c40/90-0
00:13:27.019 --> 00:13:30.603
from our technology folks.
So it's also added from delay.

af928d9a-10e2-4c06-96b3-84c31be12c40/90-1
00:13:30.603 --> 00:13:34.990
But there are companies who can do this.
Outside companies, there are,

af928d9a-10e2-4c06-96b3-84c31be12c40/90-2
00:13:34.990 --> 00:13:39.439
we're having to be just beginning work
with a company called John Snow,

af928d9a-10e2-4c06-96b3-84c31be12c40/90-3
00:13:39.439 --> 00:13:44.136
which sort of specializes in that.
There are other companies who do that as

af928d9a-10e2-4c06-96b3-84c31be12c40/90-4
00:13:44.136 --> 00:13:46.299
third party for healthcare systems.

af928d9a-10e2-4c06-96b3-84c31be12c40/92-0
00:13:47.019 --> 00:13:52.439
But given the threats to health systems
by outside bad actors and the need for

af928d9a-10e2-4c06-96b3-84c31be12c40/92-1
00:13:52.439 --> 00:13:55.870
our T&
D people to protect our health systems

af928d9a-10e2-4c06-96b3-84c31be12c40/92-2
00:13:55.870 --> 00:14:00.193
data from bad actors,
it's a very challenging thing to be able

af928d9a-10e2-4c06-96b3-84c31be12c40/91-0
00:13:57.539 --> 00:13:58.019
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/92-3
00:14:00.193 --> 00:14:04.379
to get that data de-identified and out of
the health system.

af928d9a-10e2-4c06-96b3-84c31be12c40/93-0
00:14:04.859 --> 00:14:09.504
And the last question on this topic,
since we are on a topic of generative

af928d9a-10e2-4c06-96b3-84c31be12c40/93-1
00:14:09.504 --> 00:14:13.655
artificial intelligence,
some of our listeners may have read about

af928d9a-10e2-4c06-96b3-84c31be12c40/93-2
00:14:13.655 --> 00:14:16.256
Gen.
AI reverse engineering de-identified

af928d9a-10e2-4c06-96b3-84c31be12c40/93-3
00:14:16.256 --> 00:14:20.716
patient data and taking different
elements of discrete data elements in

af928d9a-10e2-4c06-96b3-84c31be12c40/93-4
00:14:20.716 --> 00:14:23.813
that data,
matching it with data they find on the

af928d9a-10e2-4c06-96b3-84c31be12c40/93-5
00:14:23.813 --> 00:14:24.619
internet, and

af928d9a-10e2-4c06-96b3-84c31be12c40/94-0
00:14:24.699 --> 00:14:29.328
kind of reconstituting the identifiable
personal health information.

af928d9a-10e2-4c06-96b3-84c31be12c40/94-1
00:14:29.328 --> 00:14:30.939
Any thoughts about that?

af928d9a-10e2-4c06-96b3-84c31be12c40/96-0
00:14:32.619 --> 00:14:35.972
I think we're concerned about it,
is what I would say.

af928d9a-10e2-4c06-96b3-84c31be12c40/96-1
00:14:35.972 --> 00:14:40.666
I think a number of our security and
development people are working on those

af928d9a-10e2-4c06-96b3-84c31be12c40/96-2
00:14:40.666 --> 00:14:44.324
issues right now.
We work in collaboration with the Florida

af928d9a-10e2-4c06-96b3-84c31be12c40/96-3
00:14:44.324 --> 00:14:49.079
International University College of
Engineering and Computer Science as well.

af928d9a-10e2-4c06-96b3-84c31be12c40/95-0
00:14:49.019 --> 00:14:49.579
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/96-4
00:14:49.079 --> 00:14:52.859
We kind of have a three-legged stool
sometimes with industry.

af928d9a-10e2-4c06-96b3-84c31be12c40/97-0
00:14:53.099 --> 00:14:58.391
health system and our university partners,
but computer safety and protecting that

af928d9a-10e2-4c06-96b3-84c31be12c40/97-1
00:14:58.391 --> 00:15:01.899
data is become a number one priority for
us, for sure.

af928d9a-10e2-4c06-96b3-84c31be12c40/98-0
00:15:01.739 --> 00:15:07.435
So I'd like to kind of ask you,
we can go one of two ways here. One,

af928d9a-10e2-4c06-96b3-84c31be12c40/98-1
00:15:07.435 --> 00:15:11.894
we can discuss another example of
commercializing IP,

af928d9a-10e2-4c06-96b3-84c31be12c40/98-2
00:15:11.894 --> 00:15:16.187
and I know you have an interesting
example of that.

af928d9a-10e2-4c06-96b3-84c31be12c40/98-3
00:15:16.187 --> 00:15:22.379
Or it might be interesting to discuss,
it might be interesting to discuss,

af928d9a-10e2-4c06-96b3-84c31be12c40/99-0
00:15:22.459 --> 00:15:25.509
You know what, let's just dive in,
or sorry,

af928d9a-10e2-4c06-96b3-84c31be12c40/99-1
00:15:25.509 --> 00:15:29.576
broader data challenges facing the
commercialization of IP.

af928d9a-10e2-4c06-96b3-84c31be12c40/99-2
00:15:29.576 --> 00:15:34.592
So we just spoke about the difficulties
of de-identifying personal health

af928d9a-10e2-4c06-96b3-84c31be12c40/99-3
00:15:34.592 --> 00:15:39.404
information. I'm wondering, Barry,
if you have any other challenges or

af928d9a-10e2-4c06-96b3-84c31be12c40/99-4
00:15:39.404 --> 00:15:41.099
concerns when it comes to

af928d9a-10e2-4c06-96b3-84c31be12c40/100-0
00:15:41.739 --> 00:15:46.102
commercializing your IP that data
presents, any data challenges,

af928d9a-10e2-4c06-96b3-84c31be12c40/100-1
00:15:46.102 --> 00:15:50.935
interoperability, kind of normalizing,
aggregating, deduplicating data,

af928d9a-10e2-4c06-96b3-84c31be12c40/100-2
00:15:50.935 --> 00:15:56.373
getting data from one place to another,
making sure that you have the right data

af928d9a-10e2-4c06-96b3-84c31be12c40/100-3
00:15:56.373 --> 00:15:59.729
sources,
or we can just jump into another example

af928d9a-10e2-4c06-96b3-84c31be12c40/100-4
00:15:59.729 --> 00:16:01.139
of commercialization.

af928d9a-10e2-4c06-96b3-84c31be12c40/103-0
00:16:01.499 --> 00:16:04.368
Well,
I'm happy to talk about the challenges in

af928d9a-10e2-4c06-96b3-84c31be12c40/103-1
00:16:04.368 --> 00:16:08.910
getting the rich data that exists in
health systems to be de-identified and

af928d9a-10e2-4c06-96b3-84c31be12c40/103-2
00:16:08.910 --> 00:16:12.018
actually commercializable.
It sounds really simple.

af928d9a-10e2-4c06-96b3-84c31be12c40/103-3
00:16:12.018 --> 00:16:14.648
It probably sounds like the simplest
thing.

af928d9a-10e2-4c06-96b3-84c31be12c40/101-0
00:16:12.299 --> 00:16:12.619
Yeah.

af928d9a-10e2-4c06-96b3-84c31be12c40/102-0
00:16:13.859 --> 00:16:14.219
Uh-huh.

af928d9a-10e2-4c06-96b3-84c31be12c40/103-4
00:16:14.648 --> 00:16:18.832
These health systems are sitting on these
rich troves of information.

af928d9a-10e2-4c06-96b3-84c31be12c40/103-5
00:16:18.832 --> 00:16:22.419
Baptist Health in particular has a very
unique demographic.

af928d9a-10e2-4c06-96b3-84c31be12c40/105-0
00:16:22.699 --> 00:16:25.467
here,
which is very widely wanted by many

af928d9a-10e2-4c06-96b3-84c31be12c40/105-1
00:16:25.467 --> 00:16:29.422
pharma companies,
many medical device companies, and so on.

af928d9a-10e2-4c06-96b3-84c31be12c40/104-0
00:16:27.019 --> 00:16:27.259
Hmm.

af928d9a-10e2-4c06-96b3-84c31be12c40/105-2
00:16:29.422 --> 00:16:33.245
There are different data sets that have
very rich assets.

af928d9a-10e2-4c06-96b3-84c31be12c40/105-3
00:16:33.245 --> 00:16:38.254
But it turns out delivering that actual
data is probably one of the hardest

af928d9a-10e2-4c06-96b3-84c31be12c40/105-4
00:16:38.254 --> 00:16:42.539
challenges we've ever faced.
And here are some of the obstacles.

af928d9a-10e2-4c06-96b3-84c31be12c40/108-0
00:16:42.699 --> 00:16:46.045
One is internal resistance to moving that
data around.

af928d9a-10e2-4c06-96b3-84c31be12c40/108-1
00:16:46.045 --> 00:16:50.426
There are people who have 0 tolerance or
zero risk tolerance, you know,

af928d9a-10e2-4c06-96b3-84c31be12c40/108-2
00:16:50.426 --> 00:16:55.112
within the big healthcare organization,
rightly so, not disagreeing with it,

af928d9a-10e2-4c06-96b3-84c31be12c40/108-3
00:16:55.112 --> 00:16:59.310
that we have to work with.
So it's not just a question of innovation

af928d9a-10e2-4c06-96b3-84c31be12c40/106-0
00:16:56.939 --> 00:16:57.419
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/108-4
00:16:59.310 --> 00:17:02.779
saying, hey, you know, we want that data,
give it to us.

af928d9a-10e2-4c06-96b3-84c31be12c40/109-0
00:17:03.179 --> 00:17:07.359
No, it doesn't happen like that.
It's like a two or three-year project.

af928d9a-10e2-4c06-96b3-84c31be12c40/107-0
00:17:03.299 --> 00:17:03.779
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/109-1
00:17:07.359 --> 00:17:11.714
We've been working with a number of
different organizations and our T&

af928d9a-10e2-4c06-96b3-84c31be12c40/109-2
00:17:11.714 --> 00:17:16.185
D people. That's number one. Number 2,
getting the data into a useful format

af928d9a-10e2-4c06-96b3-84c31be12c40/109-3
00:17:16.185 --> 00:17:20.656
requires money, time, and effort.
It's not just a bunch of random data sets.

af928d9a-10e2-4c06-96b3-84c31be12c40/109-4
00:17:20.656 --> 00:17:21.179
Number 3,

af928d9a-10e2-4c06-96b3-84c31be12c40/111-0
00:17:22.059 --> 00:17:25.701
Certain types of data sets are unique.
So for instance,

af928d9a-10e2-4c06-96b3-84c31be12c40/111-1
00:17:25.701 --> 00:17:30.773
cancer management or cardiovascular
management may need imaging data combined

af928d9a-10e2-4c06-96b3-84c31be12c40/111-2
00:17:30.773 --> 00:17:34.935
with EMR data. Okay,
and it needs to be matched up in some way.

af928d9a-10e2-4c06-96b3-84c31be12c40/111-3
00:17:34.935 --> 00:17:40.203
And so the data wonks and people who are
actually really involved in making this

af928d9a-10e2-4c06-96b3-84c31be12c40/110-0
00:17:35.539 --> 00:17:36.139
Mm-hmm.

af928d9a-10e2-4c06-96b3-84c31be12c40/111-4
00:17:40.203 --> 00:17:41.179
data available,

af928d9a-10e2-4c06-96b3-84c31be12c40/113-0
00:17:41.379 --> 00:17:44.922
have to be able to get that so that it
can be packaged,

af928d9a-10e2-4c06-96b3-84c31be12c40/113-1
00:17:44.922 --> 00:17:48.466
linked together in some way if it's not
already linked.

af928d9a-10e2-4c06-96b3-84c31be12c40/113-2
00:17:48.466 --> 00:17:52.389
So I would say you need full-time people.
Within innovations,

af928d9a-10e2-4c06-96b3-84c31be12c40/113-3
00:17:52.389 --> 00:17:57.261
we have an AVP and other people who
really can talk to our technology people

af928d9a-10e2-4c06-96b3-84c31be12c40/113-4
00:17:57.261 --> 00:18:00.299
about that, you know,
from the innovation side.

af928d9a-10e2-4c06-96b3-84c31be12c40/112-0
00:18:00.179 --> 00:18:00.779
Mm-hmm.

af928d9a-10e2-4c06-96b3-84c31be12c40/114-0
00:18:01.259 --> 00:18:04.893
But it's a real challenge and you need
dedicated resources to be able to be

af928d9a-10e2-4c06-96b3-84c31be12c40/114-1
00:18:04.893 --> 00:18:05.419
successful.

af928d9a-10e2-4c06-96b3-84c31be12c40/115-0
00:18:05.899 --> 00:18:09.264
It sounds like a difficult challenge.
You know,

af928d9a-10e2-4c06-96b3-84c31be12c40/115-1
00:18:09.264 --> 00:18:12.558
pharma and medical device companies,
you said,

af928d9a-10e2-4c06-96b3-84c31be12c40/115-2
00:18:12.558 --> 00:18:15.853
would be very interested in accessing the
PHI,

af928d9a-10e2-4c06-96b3-84c31be12c40/115-3
00:18:15.853 --> 00:18:21.672
particularly because of the demographics
of the patient population that you serve.

af928d9a-10e2-4c06-96b3-84c31be12c40/115-4
00:18:21.672 --> 00:18:26.299
I guess, what is it, why, it's so,
what are the greatest, I mean,

af928d9a-10e2-4c06-96b3-84c31be12c40/116-0
00:18:26.859 --> 00:18:29.525
You want to be able,
what is your advice to other

af928d9a-10e2-4c06-96b3-84c31be12c40/116-1
00:18:29.525 --> 00:18:32.832
organizations that are looking to
monetize their data, right?

af928d9a-10e2-4c06-96b3-84c31be12c40/116-2
00:18:32.832 --> 00:18:35.925
Everybody has data that might be of some
use to startups,

af928d9a-10e2-4c06-96b3-84c31be12c40/116-3
00:18:35.925 --> 00:18:39.019
to pharmaceutical companies,
to medical device companies,

af928d9a-10e2-4c06-96b3-84c31be12c40/116-4
00:18:39.019 --> 00:18:42.592
and they want to monetize it.
They want to increase their margins,

af928d9a-10e2-4c06-96b3-84c31be12c40/116-5
00:18:42.592 --> 00:18:46.219
but they have the same challenges that
you've just been discussing.

af928d9a-10e2-4c06-96b3-84c31be12c40/117-0
00:18:46.459 --> 00:18:51.243
As we wrap up this podcast episode,
I'd like to ask you to just reflect upon

af928d9a-10e2-4c06-96b3-84c31be12c40/117-1
00:18:51.243 --> 00:18:55.779
how you've been able to overcome these
challenges and any advice to your

af928d9a-10e2-4c06-96b3-84c31be12c40/117-2
00:18:55.779 --> 00:19:00.004
colleagues across the country who may be
interested in also kind of

af928d9a-10e2-4c06-96b3-84c31be12c40/117-3
00:19:00.004 --> 00:19:05.099
commercializing their data and they're
just kind of stuck with it and frustrated.

af928d9a-10e2-4c06-96b3-84c31be12c40/118-0
00:19:05.299 --> 00:19:08.505
We have this demand over here,
we have the supply over here,

af928d9a-10e2-4c06-96b3-84c31be12c40/118-1
00:19:08.505 --> 00:19:12.605
but we have so many challenges releasing
that data to those who demand it and

af928d9a-10e2-4c06-96b3-84c31be12c40/118-2
00:19:12.605 --> 00:19:13.499
would pay for it.

af928d9a-10e2-4c06-96b3-84c31be12c40/119-0
00:19:14.299 --> 00:19:19.464
Well, like most things in healthcare,
successful innovation is a team sport.

af928d9a-10e2-4c06-96b3-84c31be12c40/119-1
00:19:19.464 --> 00:19:22.818
And I think as it relates to this
specific issue,

af928d9a-10e2-4c06-96b3-84c31be12c40/119-2
00:19:22.818 --> 00:19:27.379
close collaboration between our director
of technology and digital,

af928d9a-10e2-4c06-96b3-84c31be12c40/119-3
00:19:27.379 --> 00:19:32.343
which maybe didn't exist three or four
years ago, has been developed now.

af928d9a-10e2-4c06-96b3-84c31be12c40/119-4
00:19:32.343 --> 00:19:35.899
And I think our biggest secret to success
ultimately

af928d9a-10e2-4c06-96b3-84c31be12c40/120-0
00:19:36.139 --> 00:19:40.624
is going to be that close cooperation
between the innovation program and the

af928d9a-10e2-4c06-96b3-84c31be12c40/120-1
00:19:40.624 --> 00:19:45.401
people that are responsible for use of
that data internally in the health system,

af928d9a-10e2-4c06-96b3-84c31be12c40/120-2
00:19:45.401 --> 00:19:49.595
whatever that title might be.
It varies from organization. In our case,

af928d9a-10e2-4c06-96b3-84c31be12c40/120-3
00:19:49.595 --> 00:19:54.022
it's the Chief Data Officer or the Chief,
he's called the corporate head of

af928d9a-10e2-4c06-96b3-84c31be12c40/120-4
00:19:54.022 --> 00:19:57.459
technology and digital.
But he's responsible for all data.

af928d9a-10e2-4c06-96b3-84c31be12c40/122-0
00:19:58.299 --> 00:20:02.199
And I think having a close relationship
to the people that are interested in

af928d9a-10e2-4c06-96b3-84c31be12c40/122-1
00:20:02.199 --> 00:20:06.149
using that data and the people who are
interested in protecting that data and

af928d9a-10e2-4c06-96b3-84c31be12c40/121-0
00:20:03.539 --> 00:20:04.019
Mhm.

af928d9a-10e2-4c06-96b3-84c31be12c40/122-2
00:20:06.149 --> 00:20:08.479
aligning,
like everything else in healthcare,

af928d9a-10e2-4c06-96b3-84c31be12c40/122-3
00:20:08.479 --> 00:20:12.379
aligning everybody's incentives is one of
the secrets to success, I believe.

af928d9a-10e2-4c06-96b3-84c31be12c40/123-0
00:20:13.259 --> 00:20:16.077
Well, Barry,
I'd like to thank you so much for joining

af928d9a-10e2-4c06-96b3-84c31be12c40/123-1
00:20:16.077 --> 00:20:16.539
us today.

af928d9a-10e2-4c06-96b3-84c31be12c40/124-0
00:20:17.419 --> 00:20:20.620
Thank you.
I hope it was of some information for you

af928d9a-10e2-4c06-96b3-84c31be12c40/124-1
00:20:20.620 --> 00:20:23.339
and for everyone who's listening.
Thank you.